Mackenzie Financial Corp Cuts Position in HCA Healthcare, Inc. $HCA

Mackenzie Financial Corp reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 6.9% during the 2nd quarter, Holdings Channel reports. The firm owned 100,615 shares of the company’s stock after selling 7,512 shares during the quarter. Mackenzie Financial Corp’s holdings in HCA Healthcare were worth $38,546,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in HCA. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank acquired a new stake in HCA Healthcare in the 1st quarter worth about $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare during the first quarter valued at approximately $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the second quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.4%

Shares of NYSE:HCA opened at $512.94 on Monday. The business has a 50-day moving average price of $452.07 and a 200 day moving average price of $406.66. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $520.00. The company has a market capitalization of $117.05 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same period last year, the business earned $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

Wall Street Analysts Forecast Growth

HCA has been the topic of several research reports. JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Wells Fargo & Company boosted their target price on HCA Healthcare from $412.00 to $431.00 and gave the stock an “equal weight” rating in a report on Thursday, November 13th. Sanford C. Bernstein reiterated a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research report on Monday, October 27th. Bank of America raised their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Cowen reissued a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average target price of $474.53.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.